Orchid Pharma Shares Shot Up 9% on DCGI Approval for UTI Treatment Drug – Equitypandit
Shares of Orchid Pharma Ltd shot-up 9% higher on 6 June after the company announced receiving approval from the Drugs Controller General of India (DCGI) to market the company’s antibiotic drug combination that is used for the treatment of complicated urinary tract infection (UTI). The company in its regulatory filing said that the DCGI has…